TNGX News and Press, Tango Therapeutics Inc. From 10/09/23

2023-10-09 11:53:07 ET Shares of Tango Therapeutics (NASDAQ: TNGX) were down more than 12% as of 11:15 a.m. on Monday. The healthcare stock is up more than 37% this year. Tango is a clinical-stage biotech that focuses on precision oncology therapies. The stock reached a ...

2023-10-09 10:00:00 ET More on Health Care Select Sector SPDR Citi turns cautious on pharmaceuticals and biotech BofA Securities: Which small cap non-earner stocks to avoid For further details see: Bioline Rx, Clever Leaves among healthcare movers

2023-09-26 07:38:47 ET DENVER, Colo., Sept 26, 2023 ( www.247marketnews.com )- The following stocks are the top performing U.S. stocks over the past week; Vaccitech (NASDAQ:VACC), Lifezone Metals (NYSE:LZM), Globus Maritime Ltd. (NASDAQ:GLBS), Siyata Mobile (NASDAQ:SYTA), ESS Tech (NYSE...

2023-09-18 17:06:48 ET Gainers: Gain Therapeutics ( NASDAQ: GANX ) +7% . QuidelOrtho  ( QDEL ) +5% . ARS Pharmaceuticals ( SPRY ) +5% . ProFrac Holding  ( ACDC ) +5% . Clean Energy Fuels  ( CLNE ) +4% . L...

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have been selected for poster presentations at ...

2023-09-14 17:55:00 ET Shares of Tango Therapeutics (NASDAQ: TNGX) were up 16.7% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech company's stock closed at $7.06 last week, then rose as high as...

BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Co...

BOSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics , Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Office...

2023-08-30 17:09:39 ET Gainers: Okta ( OKTA ) +10% . NanoString Technologies ( NSTG ) +5% . First Interstate BancSystem ( FIBK ) +4% . Destination XL Group ( DXLG ) +4% . Avidity Biosciences ( RNA ) +4% . Losers: Five Bel...

BOSTON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced changes to its Board of Directors. John Ketchum has been appointed t...